drugset / Trial / NCT07085559
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
NaSequentialOpen-labelTreatment
Summary
A Study of Metabolically Armed BCMA CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Plasma Cell Neoplasms.
Timeline
- Start
- 2025-06-23
- Primary completion
- 2027-06-30
- Completion
- 2027-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metabolically Armed BCMA CAR-T cells | Cell therapy | — | Intravenous |